Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 29 · 1 feed behind: Insider filings, 7 days · Every feed →

More filters
Clear filters

Insiders · $100K+ · 36,164 trades

Trades
36,164
Buys 3,392 · Sells 32,772
People
6,565
Stocks
2,299
Disclosed value
$141B
range midpoints · Congress & executive
Filed late
2,508
  1. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  2. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  3. ▼ SELLFidelity & Guaranty Life Insurance Co 10% ownerCCAP Crescent Capital BDC, Inc.$1.4Mdisclosed Sep 9 · filed the same day
  4. ▼ SELLSilver Lake Group, L.L.C. DirectorDELL Dell Technologies Inc.$1.7Mdisclosed Sep 9 · filed 5 days after the trade · late
  5. ▼ SELLSilver Lake Technology Associates V, L.P. DirectorDELL Dell Technologies Inc.$1.5Mdisclosed Sep 9 · filed 5 days after the trade · late
  6. ▼ SELLSl Spv-2, L.P. DirectorDELL Dell Technologies Inc.$2.6Mdisclosed Sep 9 · filed 5 days after the trade · late
  7. ▼ SELLSl Spv-2, L.P. DirectorDELL Dell Technologies Inc.$2.7Mdisclosed Sep 9 · filed 5 days after the trade · late
  8. ▼ SELLSilver Lake Partners IV, L.P. DirectorDELL Dell Technologies Inc.$1.1Mdisclosed Sep 9 · filed 5 days after the trade · late
  9. ▼ SELLMark W. Webb EVP, CFO & COOJILL J.Jill, Inc.$102Kdisclosed Sep 9 · filed 5 days after the trade · late
  10. ▼ SELLSlta Spv-2, L.P. DirectorDELL Dell Technologies Inc.$3Mdisclosed Sep 9 · filed 5 days after the trade · late
  11. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  12. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  13. ▼ SELLEgon Durban DirectorDELL Dell Technologies Inc.$3.2Mdisclosed Sep 9 · filed 5 days after the trade · late
  14. ▲ BUYPaul Glavine Chief Growth OfficerHELP Helus Pharma Inc.$1Mdisclosed Sep 9 · filed 9 days after the trade · late
  15. ▼ SELLKenneth R Bull COOFIVE Five Below, Inc$273Kdisclosed Sep 9 · filed 5 days after the trade · late
  16. ▼ SELLKenneth R Bull COOFIVE Five Below, Inc$660Kdisclosed Sep 9 · filed 5 days after the trade · late
  17. ▼ SELLKeith D Larson General Counsel and SecretaryVG Venture Global, Inc.$28.7Mdisclosed Sep 9 · filed the same day
  18. ▼ SELLEgon Durban DirectorDELL Dell Technologies Inc.$2Mdisclosed Sep 9 · filed 5 days after the trade · late
  19. ▼ SELLEgon Durban DirectorDELL Dell Technologies Inc.$183Kdisclosed Sep 9 · filed 5 days after the trade · late
  20. ▼ SELLJason Hulse Murray Co-Founder, CEO & ChairmanPACS PACS Group, Inc.$916Kdisclosed Sep 9 · filed 1 day after the trade
  21. ▼ SELLJason Hulse Murray Co-Founder, CEO & ChairmanPACS PACS Group, Inc.$974Kdisclosed Sep 9 · filed 5 days after the trade · late
  22. ▼ SELLYu-Hsin Lin Chief Executive OfficerBLTE Belite Bio, Inc$475Kdisclosed Sep 9 · filed 5 days after the trade · late
  23. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  24. ▼ SELLHao-Yuan Chuang Chief Financial OfficerBLTE Belite Bio, Inc$908Kdisclosed Sep 9 · filed 1 day after the trade
  25. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late